Safety of intravenously applied mistletoe extract – results from a phase I dose escalation study in patients with advanced cancer

Mistletoe extracts have anti-tumor properties and are approved for subcutaneous use in cancer patients. Data on Intravenous application are limited.

Source: BMC Complementary and Alternative Medicine - September 18, 2017 Category: Complementary Medicine Authors: Roman Huber, Dietrich Schlodder, Carola Effertz, Sabine Rieger and Wilfried Tr öger Tags: Research article Source Type: research